4.77
Mimedx Group Inc stock is traded at $4.77, with a volume of 37,744.
It is up +0.00% in the last 24 hours and up +10.16% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$4.77
Open:
$4.79
24h Volume:
37,744
Relative Volume:
0.03
Market Cap:
$699.66M
Revenue:
$389.42M
Net Income/Loss:
$30.70M
P/E Ratio:
23.35
EPS:
0.2043
Net Cash Flow:
$67.23M
1W Performance:
+2.80%
1M Performance:
+10.16%
6M Performance:
+15.78%
1Y Performance:
-32.05%
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG vs PSNYW, GOODO, SHMD, CHAD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
|
PSNYW
Polestar Automotive Holding Uk
|
4.58 | 663.69M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.46 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.68 | 222.94M | 52.15M | -21.46M | 0 | -0.4675 |
|
CHAD
Direxion Daily CSI 300 China A
|
8.60 | 197.39M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.00 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-23-26 | Initiated | Citizens | Mkt Outperform |
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
Two New York conferences will include MIMEDX executives on Sept. 9 and 10 - Stock Titan
MIMEDX GROUP, INC. SEC Filing (Sep 8, 2026) - Stock Titan
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - The Globe and Mail
MDXG Should I Buy - Intellectia AI
MiMedx Group (NASDAQ: MDXG) readies shares for business combination - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc.MDXG - Eastern Progress
Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan
MiMedx (MDXG) Earnings Metrics: The Bottom-Line Figure Trails Its Comparison at the Close; Immediate Response: Shares Move 3.58% Up on the DayEnergy Earnings Report - vinanet.vn
MDXG Q2 2026 Earnings: Wider-than-Expected Loss as EPS Misses Estimates by 106%Post-Announcement Reaction - vinanet.vn
Tranche Update on MiMedx Group, Inc.'s Equity Buyback Plan announced on February 25, 2026. - marketscreener.com
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
MiMedx Group, Inc (MDXG) Stock Report: Exploring a 63.93% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MiMedx Group, Inc Revenue Breakdown – NASDAQ:MDXG - TradingView
MiMedx Group (MDXG) Climbs 3.83% to $4.34, Approaching Key Resistance LevelSpring Pattern - vinanet.vn
MiMedx (MDXG) Q2 2026 Earnings Call Transcript - AOL.com
MiMedx Group Inc (MDXG) Stock News Today - TradingKey
MiMedx Group's (NASDAQ:MDXG) Soft Earnings Are Actually Better Than They Appear - simplywall.st
Lazard Asset Management LLC Sells 264,718 Shares of MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group (MDXG) Holds Steady Near $4.24 as Consolidation ContinuesExtension Target - vinanet.vn
MiMedx Group (NASDAQ:MDXG) Stock Price Up 7.8%What's Next? - MarketBeat
Renaissance Technologies LLC Has $11.93 Million Stake in MiMedx Group, Inc $MDXG - MarketBeat
Wall Street Zen Downgrades MiMedx Group (NASDAQ:MDXG) to Sell - MarketBeat
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
MiMedx to acquire Sanara MedTech for $350M - MassDevice
MiMedx Group affirms FY26 sales guidance of $260-290M - scanx.trade
MiMedx Group Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
MiMedx Group Q2 Earnings Call Highlights - tradingview.com
MiMedx Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is MiMedx Group Inc (MDXG) Undervalued After Q2 Earnings Beat? E - GuruFocus
MiMedx: Q2 Earnings Snapshot - Marietta Daily Journal
MIMEDX to Acquire Sanara MedTech - The Manila Times
MIMEDX Announces Second Quarter 2026 Operating & Financial Results - GlobeNewswire
MiMedx agrees to buy Sanara MedTech for $35 a share (SMTI:NASDAQ) - Seeking Alpha
Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside - GuruFocus
MiMedx Group Inc (MDXG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MiMedx Group Inc (MDXG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MiMedx Group Inc (MDXG) Earnings Date & Reports & Earnings News - tradingkey.com
MiMedx Group Inc (MDXG) Institutional Confidence - TradingKey
MiMedx Group Inc (MDXG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MiMedx Group Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
MiMedx Group Inc (MDXG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MiMedx Group Inc (MDXG) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
MDXG|MiMedx Group Inc|Price:4.340|Chg%:+0.080 - TradingKey
Paradigm Capital Management Inc. NY Boosts Stock Position in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group, Inc Revenue Breakdown – BOATS:MDXG - TradingView
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mimedx Group Inc Stock (MDXG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hulse William Frank IV | General Counsel and CAO |
Mar 10 '26 |
Option Exercise |
4.50 |
136,364 |
613,638 |
624,900 |
| DOUG RICE | Chief Financial Officer |
Mar 10 '26 |
Option Exercise |
4.50 |
243,000 |
1,093,500 |
508,678 |
| Maersk-Moller Kimberly | Chief Commercial Officer |
Nov 06 '25 |
Sale |
7.42 |
58,300 |
432,329 |
236,982 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):